IGC Pharma Q1 EPS $(0.04) Up From $(0.05) YoY, Sales $555.00K Up From $212.00K YoY
Portfolio Pulse from Happy Mohamed
IGC Pharma reported Q1 losses of $(0.04) per share, a 20% improvement from $(0.05) per share YoY. The company's sales also increased by 161.79% to $555.00K from $212.00K YoY.
August 14, 2023 | 1:04 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
IGC Pharma's Q1 earnings show a decrease in losses and a significant increase in sales YoY.
IGC Pharma's Q1 earnings report shows a decrease in losses and a significant increase in sales compared to the same period last year. This indicates a positive financial performance, which could potentially lead to a rise in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100